Your browser doesn't support javascript.
loading
Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer.
Arbour, Kathryn C; Rizvi, Hira; Plodkowski, Andrew J; Hellmann, Matthew D; Knezevic, Andrea; Heller, Glenn; Yu, Helena A; Ladanyi, Marc; Kris, Mark G; Arcila, Maria E; Rudin, Charles M; Lito, Piro; Riely, Gregory J.
Afiliación
  • Arbour KC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. arbourk@mskcc.org.
  • Rizvi H; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Plodkowski AJ; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hellmann MD; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Knezevic A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Heller G; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Yu HA; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Ladanyi M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kris MG; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Arcila ME; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rudin CM; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Lito P; Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Clin Cancer Res ; 27(8): 2209-2215, 2021 04 15.
Article en En | MEDLINE | ID: mdl-33558425

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos